Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
Mitochondrial and nuclear genes as the cause of complex I deficiency.
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Managed care aspects of managing multiple sclerosis.
Urinary tract infections in multiple sclerosis: under-diagnosed and under-treated? A clinical audit at a large University Hospital.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Deimination restores inner retinal visual function in murine demyelinating disease.
Confounding underlies the apparent 'month of birth' effect in multiple sclerosis.
Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy.
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus.
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
Functional plasticity of the visual system in multiple sclerosis.
Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study.
JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
Natalizumab in clinical practice: managing the risks, enjoying the benefits.
Multiple sclerosis.
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants.
Pain in multiple sclerosis: A systematic review of neuroimaging studies.
Moyamoya disease can masquerade as multiple sclerosis.

Pages